European Journal of Cancer
Volume 46, Issue 1 , Pages 95-101 , January 2010

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence

The paper is dedicated to Prof. Dr. Alfred Schauer (Göttingen) on the occasion of his 80th birthday. He has been one of the driving forces for this and for previous studies of the German Breast Cancer Study Group (GBSG) that have led to the introduction of breast-conserving therapy in Germany. He contributed his internationally recognised expertise in the central histopathological assessment of breast tumours.

  • K.-J. Winzer

      Affiliations

    • Interdisciplinary Breast Cancer, Charité Universitätsmedizin, Berlin, Germany
    • ,
  • W. Sauerbrei

      Affiliations

    • Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany
    • ,
  • M. Braun

      Affiliations

    • Department of Gynaecology, Zentralkrankenhaus Bremen-Nord, Germany
    • ,
  • T. Liersch

      Affiliations

    • Department of Surgery, Universitätsmedizin Gottingen, Germany
    • ,
  • J. Dunst

      Affiliations

    • Department of Radiotherapy, Universitätsklinikum Halle, Germany
    • ,
  • H. Guski

      Affiliations

    • Institute of Pathology, Universitätsklinikum Charité, Berlin, Germany
    • ,
  • M. Schumacher

      Affiliations

    • Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany
    • Corresponding Author InformationCorresponding author: Address: Universitätsklinikum Freiburg, Med. Biometrie und Informatik, Stefan-Meier-Str. 26, D-79104 Freiburg, Germany. Tel.: +49 (0)761 203 6661; fax: +49 (0)761 203 6680.
    • ,
  • for the German Breast Cancer Study Group (GBSG)

Received 31 July 2009

References 

  1. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. New Engl J Med. 2009;360:63–70
  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002;347:1233–1241
  3. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659–1664
  4. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–713
  5. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–2333
  6. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003
  7. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Brit J Cancer. 2001;84:164–169
  8. Fisher B, Bryant J, Dignam D, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–4149
  9. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087–106.
  10. Winzer K-J, Sauer R, Sauerbrei W, et al. for the German Breast Cancer Study Group (GBSG) Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer. 2004;40:998–1005
  11. Bloom HJG, Richardson WW. Histological grading and prognosis in primary breast cancer. Brit J Cancer. 1957;2:359–377
  12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. JASA. 1958;54:457–481
  13. Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc, Ser B. 1972;34:187–220
  14. Rauschecker HF, Sauerbrei W, Gatzemeier W, et al. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. Eur J Cancer. 1998;34:315–323
  15. Blamey RW, Chetty U, Bates T , et al. On behalf of the BASO (British Association of Surgical Oncology) II Trialists Radiotherapy and/or Tamoxifen after conserving surgery for breast cancer of excellent prognosis: BASO II TRIAL. Eur J Cancer Suppl. 2007;5:4
  16. Pötter R, Gnant M, Werner K, et al. Lumpectomy plus tamoxifen or Anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Biol Phys. 2007;68:334–340
  17. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. New Engl J Med. 2004;351(10):963–970
  18. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus Tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. New Engl J Med. 2004;351(10):971–977
  19. Killander F, Anderson H, Ryden S, et al. Radiotherapy and Tamoxifen after mastectomy in postmenopausal women – 20 years follow-up of the South Sweden Breast Cancer group randomised trial SSBGG II:I. Eur J Cancer. 2007;43:2100–2108

PII: S0959-8049(09)00732-1

doi: 10.1016/j.ejca.2009.10.007

European Journal of Cancer
Volume 46, Issue 1 , Pages 95-101 , January 2010

Article Tools

* Image Usage & Resolution